{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T21:28:13Z","timestamp":1788038893642,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ijcard.2024.131933","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T00:07:35Z","timestamp":1709424455000},"page":"131933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Impact of statin adherence and interruption within 6\u00a0months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI"],"prefix":"10.1016","volume":"405","author":[{"given":"Federico","family":"Giacobbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Annone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Morena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Di Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Carmagnola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Nebiolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Rollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Ravetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Troncone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Pancotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidio","family":"De Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Gaido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Fariselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"D'Ascenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Giammaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano Maria","family":"De Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijcard.2024.131933_bb0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamacardio.2016.4320","article-title":"Statins and the prevention of heart disease","volume":"2","author":"Ziaeian","year":"2017","journal-title":"JAMA Cardiol."},{"issue":"17","key":"10.1016\/j.ijcard.2024.131933_bb0010","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1001\/archinte.166.17.1814","article-title":"The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials","volume":"166","author":"Hulten","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"13","key":"10.1016\/j.ijcard.2024.131933_bb0015","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.ijcard.2024.131933_bb0020","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131933_bb0025","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jacl.2010.08.026","article-title":"The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review","volume":"4","author":"Simpson","year":"2010","journal-title":"J. Clin. Lipidol."},{"issue":"7","key":"10.1016\/j.ijcard.2024.131933_bb0030","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.amjcard.2013.12.012","article-title":"Influence of high-dose highly efficient statins on short-term mortality in patients undergoing percutaneous coronary intervention with stenting for acute coronary syndromes","volume":"113","author":"Tentzeris","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2024.131933_bb0035","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.amjcard.2014.02.034","article-title":"Meta-analysis of time-related benefits of statin therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"113","author":"Navarese","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131933_bb0040","first-page":"685","article-title":"Patterns of statin use in a real-world population of patients at high cardiovascular risk","volume":"22","author":"Lin","year":"2016","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.ijcard.2024.131933_bb0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ahj.2019.10.001","article-title":"Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: insights from the BleeMACS and RENAMI registries","volume":"220","author":"D\u2019Ascenzo","year":"2020","journal-title":"Am. Heart J."},{"issue":"8","key":"10.1016\/j.ijcard.2024.131933_bb0050","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamacardio.2017.0911","article-title":"Adherence to high-intensity statins following a myocardial infarction hospitalization among Medicare beneficiaries","volume":"2","author":"Colantonio","year":"2017","journal-title":"JAMA Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2024.131933_bb0055","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ehjqcco\/qcab024","article-title":"High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study","volume":"8","author":"May","year":"2022","journal-title":"European Heart J. - Quality of Care and Clinical Outcomes."},{"issue":"7","key":"10.1016\/j.ijcard.2024.131933_bb0060","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/2047487314540385","article-title":"Long-term medication adherence in patients with ST-elevation myocardial infarction and primary percutaneous coronary intervention","volume":"22","author":"Reuter","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"33","key":"10.1016\/j.ijcard.2024.131933_bb0065","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.2174\/138161211798220891","article-title":"Statin discontinuation in high-risk patients: a systematic review of the evidence","volume":"17","author":"Gomez Sandoval","year":"2011","journal-title":"CPD"},{"issue":"7","key":"10.1016\/j.ijcard.2024.131933_bb0070","doi-asserted-by":"crossref","first-page":"e011378","DOI":"10.1161\/JAHA.118.011378","article-title":"It\u2019s not too late to improve statin adherence: association between changes in statin adherence from before to after acute myocardial infarction and all-cause mortality","volume":"8","author":"Hickson","year":"2019","journal-title":"JAHA"},{"issue":"22","key":"10.1016\/j.ijcard.2024.131933_bb0075","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.jacc.2022.04.003","article-title":"Updates on the management of STEMI in 2021: beyond COVID-19","volume":"79","author":"Verdoia","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131933_bb0080","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jacl.2010.08.026","article-title":"The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review","volume":"4","author":"Simpson","year":"2010","journal-title":"J. Clin. Lipidol."},{"issue":"14","key":"10.1016\/j.ijcard.2024.131933_bb0085","doi-asserted-by":"crossref","first-page":"e025813","DOI":"10.1161\/JAHA.122.025813","article-title":"Intensity of and adherence to lipid-lowering therapy as predictors of major adverse cardiovascular outcomes in patients with coronary heart disease","volume":"11","author":"Mazhar","year":"2022","journal-title":"JAHA"},{"issue":"3","key":"10.1016\/j.ijcard.2024.131933_bb0090","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/ehjqcco\/qcab024","article-title":"High-statin adherence over 5 years of follow-up is associated with improved cardiovascular outcomes in patients with atherosclerotic cardiovascular disease: results from the IMPRES study","volume":"8","author":"May","year":"2022","journal-title":"European Heart J. - Quality of Care and Clinical Outcomes."},{"issue":"3","key":"10.1016\/j.ijcard.2024.131933_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"issue":"15","key":"10.1016\/j.ijcard.2024.131933_bb0100","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijcard.2024.131933_bb0105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41569-018-0098-5","article-title":"Safety and efficacy of statin therapy","volume":"15","author":"Adhyaru","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131933_bb0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jacc.2015.05.030","article-title":"Utilization of and adherence to guideline-recommended lipid-lowering therapy after acute coronary syndrome","volume":"66","author":"Hirsh","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.ijcard.2024.131933_bb0115","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"9753","key":"10.1016\/j.ijcard.2024.131933_bb0120","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(10)60310-8","article-title":"Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial","volume":"376","author":"Group S of the E of AR in C and H (SEARCH) C","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijcard.2024.131933_bb0125","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary SyndromesPhase Z of the a to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ijcard.2024.131933_bb0130","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/CIRCULATIONAHA.113.003589","article-title":"Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction","volume":"129","author":"Arnold","year":"2014","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ijcard.2024.131933_bb0135","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.jacc.2014.08.041","article-title":"Implications of the 2013 ACC\/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry","volume":"64","author":"Maddox","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2024.131933_bb0140","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/00015385.2020.1794162","article-title":"In-hospital statin initiation characteristics and one-year statin adherence rates in patients hospitalised for acute coronary syndrome","volume":"76","author":"\u015eim\u015fek","year":"2021","journal-title":"Acta Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131933_bb0145","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.amjcard.2014.06.009","article-title":"Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event","volume":"114","author":"Muntner","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2024.131933_bb0150","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.clinthera.2009.10.002","article-title":"Predictors of medication nonadherence among patients with diabetes in Medicare part D programs: a retrospective cohort study","volume":"31","author":"Yang","year":"2009","journal-title":"Clin. Ther."},{"issue":"4","key":"10.1016\/j.ijcard.2024.131933_bb0155","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ahj.2007.12.011","article-title":"Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease","volume":"155","author":"Ho","year":"2008","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2024.131933_bb0160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamacardio.2018.4936","article-title":"Association of Statin Adherence with Mortality in patients with atherosclerotic cardiovascular disease","volume":"4","author":"Rodriguez","year":"2019","journal-title":"JAMA Cardiol."},{"issue":"17","key":"10.1016\/j.ijcard.2024.131933_bb0165","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/archinte.166.17.1842","article-title":"Impact of medication therapy discontinuation on mortality after myocardial infarction","volume":"166","author":"Ho","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131933_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ahj.2015.04.011","volume":"170","author":"O\u2019Brien","year":"2015","journal-title":"Am. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2024.131933_bb0175","doi-asserted-by":"crossref","first-page":"e2113186","DOI":"10.1001\/jamanetworkopen.2021.13186","article-title":"Cardiovascular outcomes and mortality associated with discontinuing statins in older patients receiving polypharmacy","volume":"4","author":"Rea","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.ijcard.2024.131933_bb0180","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/acr.21643","article-title":"Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study","volume":"64","author":"De Vera","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"4","key":"10.1016\/j.ijcard.2024.131933_bb0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40263-017-0420-5","article-title":"Statin adherence and the risk of stroke: a dose-response Meta-analysis","volume":"31","author":"Xu","year":"2017","journal-title":"CNS Drugs"},{"issue":"23_suppl_1","key":"10.1016\/j.ijcard.2024.131933_bb0190","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ijcard.2024.131933_bb0195","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/aje\/kwv255","article-title":"Statins and risk of bleeding: an analysis to evaluate possible Bias due to prevalent users and healthy user aspects","volume":"183","author":"van Rein","year":"2016","journal-title":"Am. J. Epidemiol."},{"issue":"14","key":"10.1016\/j.ijcard.2024.131933_bb0200","doi-asserted-by":"crossref","first-page":"e025813","DOI":"10.1161\/JAHA.122.025813","article-title":"Intensity of and adherence to lipid-lowering therapy as predictors of major adverse cardiovascular outcomes in patients with coronary heart disease","volume":"11","author":"Mazhar","year":"2022","journal-title":"JAHA"},{"issue":"2","key":"10.1016\/j.ijcard.2024.131933_bb0205","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ehjcvp\/pvaa010","article-title":"Low adherence to statin treatment during the 1st year after an acute myocardial infarction is associated with increased 2nd-year mortality risk\u2014an inverse probability of treatment weighted study on 54 872 patients","volume":"7","author":"Khalaf","year":"2021","journal-title":"European Heart J. - Cardiovas. Pharma."},{"issue":"7","key":"10.1016\/j.ijcard.2024.131933_bb0210","first-page":"273","article-title":"Adherence to statin treatment following a myocardial infarction: an Italian population-based survey","volume":"1","author":"Monaldi","year":"2015","journal-title":"Clinicoecon Outcomes Res."},{"issue":"4","key":"10.1016\/j.ijcard.2024.131933_bb0215","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.amjcard.2014.11.026","article-title":"Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials","volume":"115","author":"Hsue","year":"2015","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.131933_bb0220","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.1038\/s41598-019-48540-3","article-title":"Statin treatment after acute coronary syndrome: adherence and reasons for non-adherence in a randomized controlled intervention trial","volume":"9","author":"Huber","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijcard.2024.131933_bb0225","series-title":"Multi-Drug Resistance in Cancer [Internet]","first-page":"199","article-title":"Expression and function of P-glycoprotein in Normal tissues: Effect on pharmacokinetics","author":"Staud","year":"2010"},{"issue":"11","key":"10.1016\/j.ijcard.2024.131933_bb0230","first-page":"1601","article-title":"Role of P-glycoprotein in statin drug interactions. Pharmacotherapy: the journal of human pharmacology and drug","volume":"26","author":"Holtzman","year":"2006","journal-title":"Therapy"},{"issue":"9","key":"10.1016\/j.ijcard.2024.131933_bb0235","doi-asserted-by":"crossref","first-page":"969259","DOI":"10.3389\/fcvm.2022.969259","article-title":"Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants\u2014a nationwide cohort study","volume":"8","author":"Wu","year":"2022","journal-title":"Front Cardiovasc Med."},{"issue":"2","key":"10.1016\/j.ijcard.2024.131933_bb0240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/jep.12095","article-title":"Healthy adherer effect - the pitfall in the interpretation of the effect of medication adherence on health outcomes","volume":"20","author":"Ladova","year":"2014","journal-title":"J. Eval. Clin. Pract."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324004510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324004510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T22:57:20Z","timestamp":1713999440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324004510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":48,"alternative-id":["S0167527324004510"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.131933","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of statin adherence and interruption within 6\u00a0months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.131933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131933"}}